Characterization of New Arylsulfatase A Gene Mutations Reinforces Genotype-Phenotype Correlation in Metachromatic Leukodystrophy

被引:27
作者
Cesani, Martina [1 ,3 ]
Capotondo, Alessia [1 ,4 ]
Plati, Tiziana [1 ]
Sergi, Lucia Sergi [1 ]
Fumagalli, Francesca [4 ,5 ]
Roncarolo, Maria Grazia [1 ,2 ,4 ]
Naldini, Luigi [1 ,4 ]
Comi, Giancarlo [3 ,4 ,5 ]
Sessa, Maria [2 ,3 ,5 ]
Biffi, Alessandra [1 ,2 ]
机构
[1] San Raffaele Telethon Inst Gene Therapy HSR TIGET, Milan, Italy
[2] HSR TIGET Pediat Clin Res Unit HSR TIGET PCRU, Milan, Italy
[3] Expt Neurol Inst, Milan, Italy
[4] Univ Vita Salute San Raffaele, Milan, Italy
[5] Ist Sci San Raffaele, Neurol Unit, I-20132 Milan, Italy
关键词
metachromatic leukodystrophy; arylsulfatase A; ARSA; genotype-phenotype correlation; LYSOSOMAL STORAGE DISEASES; A PSEUDODEFICIENCY; MISSENSE MUTATIONS; PREVALENCE; EXPRESSION;
D O I
10.1002/humu.21093
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Metachromatic Leukodystrophy (MLD) is a rare inherited lysosomal storage disorder caused by the deficiency of Arylsulfatase A (ARSA). The disease manifests itself with a broad spectrum of clinical variants, all characterized by progressive neurodegeneration in the central and peripheral nervous systems. The correlation between mutations in the ARSA gene, residual enzymatic activity associated with the mutated alleles and patients' phenotype, which has been extensively drawn for common ARSA mutations, has recently been expanded to rare ones. In this context, functional studies on the rare allelic variances acquire particular relevance for patients' prognostic evaluation. Here we have characterized eight newly identified ARSA mutations, through lentiviral vector-based expression studies on cell lines and ARSA defective murine fibroblasts. In each case, the residual activity associated with the new mutant allele correlates well with the patient's phenotype. Therefore, our results confirm the importance of functional characterization of mutant alleles for a precise genotype-based classification and definition of prognosis in MLD patients, which is particularly relevant for pre-symptomatic diagnosis. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:E936 / E945
页数:10
相关论文
共 33 条
[1]  
Berger J, 1997, AM J MED GENET, V69, P335, DOI 10.1002/(SICI)1096-8628(19970331)69:3<335::AID-AJMG22>3.3.CO
[2]  
2-P
[3]   Novel mutations associated with metachromatic leukodystrophy:: Phenotype and expression studies in nine Czech and Slovak patients [J].
Berná, L ;
Gieselmann, V ;
Poupetová, H ;
Hrebícek, M ;
Elleder, M ;
Ledvinová, J .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2004, 129A (03) :277-281
[4]   Metachromatic leukodystrophy - mutation analysis provides further evidence of genotype-phenotype correlation [J].
Biffi, A. ;
Cesani, M. ;
Fumagalli, F. ;
Del Carro, U. ;
Baldoli, C. ;
Canale, S. ;
Gerevini, S. ;
Amadio, S. ;
Falautano, M. ;
Rovelli, A. ;
Comi, G. ;
Roncarolo, M. G. ;
Sessa, M. .
CLINICAL GENETICS, 2008, 74 (04) :349-357
[5]   Safety of arylsulfatase a overexpression for gene therapy of metachromatic leukodystrophy [J].
Capotondo, A. ;
Cesani, M. ;
Pepe, S. ;
Fasano, S. ;
Gregori, S. ;
Tononi, L. ;
Venneri, M. A. ;
Brambilla, R. ;
Quattrini, A. ;
Ballabio, A. ;
Cosma, M. P. ;
Naldini, L. ;
Biffi, A. .
HUMAN GENE THERAPY, 2007, 18 (09) :821-836
[6]   PARTIAL ENZYME DEFICIENCIES - RESIDUAL ACTIVITIES AND THE DEVELOPMENT OF NEUROLOGICAL DISORDERS [J].
CONZELMANN, E ;
SANDHOFF, K .
DEVELOPMENTAL NEUROSCIENCE, 1984, 6 (01) :58-71
[7]   Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors [J].
Follenzi, A ;
Sabatino, G ;
Lombardo, A ;
Boccaccio, C ;
Naldini, L .
HUMAN GENE THERAPY, 2002, 13 (02) :243-260
[8]  
GIESELMANN V, 1991, AM J HUM GENET, V49, P407
[9]   ARYLSULFATASE-A PSEUDODEFICIENCY - LOSS OF A POLYADENYLYLATION SIGNAL AND N-GLYCOSYLATION SITE [J].
GIESELMANN, V ;
POLTEN, A ;
KREYSING, J ;
VONFIGURA, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (23) :9436-9440
[10]   What can cell biology tell us about heterogeneity in lysosomal storage diseases? [J].
Gieselmann, V .
ACTA PAEDIATRICA, 2005, 94 :80-86